Results 171 to 180 of about 134,309 (205)
Some of the next articles are maybe not open access.
Expert Review of Anti-infective Therapy, 2011
The frequency and spectrum of fungal infections have been increasing steadily over the last several decades. The reason for this increase may be explained by the increase in the number of immunocompromised patients due to malignancies, AIDS, invasive surgical procedures and transplantation.
openaire +2 more sources
The frequency and spectrum of fungal infections have been increasing steadily over the last several decades. The reason for this increase may be explained by the increase in the number of immunocompromised patients due to malignancies, AIDS, invasive surgical procedures and transplantation.
openaire +2 more sources
Obstetrics and Gynecology Clinics of North America, 1992
Current knowledge of fungal cell architecture and biochemistry allows limited understanding of the mode of action of presently available topical antifungal agents. Nystatin, first introduced in the 1950s for treatment of vulvovaginal candidiasis, has been surpassed by the imidazoles and triazoles as the first choice of treatment for vulvovaginal ...
openaire +2 more sources
Current knowledge of fungal cell architecture and biochemistry allows limited understanding of the mode of action of presently available topical antifungal agents. Nystatin, first introduced in the 1950s for treatment of vulvovaginal candidiasis, has been surpassed by the imidazoles and triazoles as the first choice of treatment for vulvovaginal ...
openaire +2 more sources
Clinical Microbiology Newsletter, 1982
For more than two decades, amphotericin B has been the single broad-spectrum agent for the treatment of systemic mycoses. Amphotericin B is not always effective, must be given parenterally, and is associated with a host of adverse reactions. Despite amphotericin B toxicity, until recently the systemic mycoses did not rate enough attention to prompt a ...
openaire +2 more sources
For more than two decades, amphotericin B has been the single broad-spectrum agent for the treatment of systemic mycoses. Amphotericin B is not always effective, must be given parenterally, and is associated with a host of adverse reactions. Despite amphotericin B toxicity, until recently the systemic mycoses did not rate enough attention to prompt a ...
openaire +2 more sources
Recent Progress in 1H-1,2,3-triazoles as Potential Antifungal Agents
Current Topics in Medicinal Chemistry, 2021Kashmiri Lal
exaly
Tackling the emerging threat of antifungal resistance to human health
Nature Reviews Microbiology, 2022Matthew C Fisher +2 more
exaly
An insight into the antifungal pipeline: selected new molecules and beyond
Nature Reviews Drug Discovery, 2010, Arturo Casadevall, John N Galgiani
exaly